\u5e76\u5c06\u4e8e\u660e\u5e74\u521d\u5f00\u59cb\u8fdb\u884c\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/a><\/p>\nArgenica\u5e0c\u671b\u8fd9\u79cd\u836f\u7269\u80fd\u591f\u88ab\u4e00\u7ebf\u53cd\u5e94\u8005\u7528\u6765\u4fdd\u62a4\u8111\u7ec4\u7ec7\u5728\u4e2d\u98ce\u671f\u95f4\u514d\u53d7\u635f\u4f24\uff0c\u5e76\u6709\u8fdb\u4e00\u6b65\u7684\u6f5c\u529b\u5728\u4e2d\u98ce\u53d1\u751f\u540e\u4fc3\u8fdb\u6062\u590d\u3002<\/p>\n
\u5176\u4ed6\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5<\/h2>\n
\u8be5\u4e13\u5229\u7533\u8bf7\u8fd8\u6db5\u76d6\u4e86\u8be5\u836f\u7269\u5728\u5176\u4ed6\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u4e2d\u7684\u5e94\u7528\uff0c\u5982\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u3001\u4ea8\u5ef7\u987f\u6c0f\u75c5\u3001\u591a\u53d1\u6027\u786c\u5316\u75c7\u3001\u5e15\u91d1\u68ee\u75c5\u3001\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u3001\u795e\u7ecf\u6027\u75bc\u75db\u3001\u810a\u9ad3\u635f\u4f24\u548c\u766b\u75eb\u3002<\/p>\n
\u8be5\u7814\u7a76\u4e3aARG-007\u5728\u7f8e\u56fd\u7684\u5e7f\u6cdb\u5e94\u7528\u63d0\u4f9b\u4e86\u4fe1\u5fc3\uff0c\u5982\u679cARG-007\u80fd\u591f\u83b7\u5f97\u5728\u8fd9\u4e9b\u6761\u4ef6\u4e0b\u8fdb\u884c\u5f00\u53d1\u6240\u9700\u7684\u529f\u6548\u6570\u636e\uff0cARG-007\u5c31\u53ef\u4ee5\u5728\u7f8e\u56fd\u8fdb\u884c\u5546\u4e1a\u5316\u3002<\/p>\n
\u91cd\u8981\u7684\u4e00\u6b65<\/h2>\n
Argenica\u9996\u5e2d\u6267\u884c\u5b98Liz Dallimore\u535a\u58eb\u8bf4\uff0c\u8bb8\u53ef\u901a\u77e5\u662f\u836f\u7269\u5f00\u53d1\u8fc7\u7a0b\u4e2d\u7684\u91cd\u8981\u4e00\u6b65\u3002<\/p>\n
\u5979\u8bf4:\u201c\u4e2d\u98ce\u3001\u8111\u5916\u4f24\u548cHIE\u662f\u7f8e\u56fd\u5de8\u5927\u7684\u672a\u6ee1\u8db3\u533b\u7597\u9700\u6c42\u7684\u75be\u75c5\uff0c\u4ee3\u8868\u7740\u6211\u4eec\u5c06\u5bfb\u627e\u7684\u76ee\u6807\u5e02\u573a\u3002\u201d<\/p>\n
\u201c\u6388\u4e88\u8be5\u4e13\u5229\u5c06\u589e\u5f3a\u6211\u4eec\u672a\u6765\u4e0e\u7f8e\u56fd\u5236\u836f\u516c\u53f8\u8fdb\u884c\u5546\u4e1a\u8c08\u5224\u7684\u80fd\u529b\u3002\u201d<\/p>\n
\u884c\u7a0b\u7684\u7edf\u8ba1\u6570\u636e<\/h2>\n
\u5728\u7f8e\u56fd\uff0c\u6bcf\u5e74\u7ea6\u670979.5\u4e07\u4eba\u4e2d\u98ce;150\u4e07\u4eba\u906d\u53d7\u521b\u4f24\u6027\u8111\u635f\u4f24;\u5927\u7ea6\u6bcf1000\u4e2a\u6d3b\u4ea7\u513f\u4e2d\u5c31\u67094\u4e2a\uff0c\u591a\u8fbe60%\u7684\u65e9\u4ea7\u513f\u60a3\u6709HIE\u3002<\/p>\n
Argenica\u5df2\u7ecf\u4e3aARG-007\u5728\u6b27\u76df(11\u4e2a\u4e3b\u8981\u56fd\u5bb6\u9a8c\u8bc1)\u3001\u65e5\u672c\u548c\u4e2d\u56fd\u7684\u5927\u578b\u6f5c\u5728\u5e02\u573a\u6388\u4e88\u4e86\u4e13\u5229\u3002<\/p>\n
\u8fd9\u4e9b\u4e13\u5229\u5b8c\u5168\u5f52\u963f\u6839\u5ef7\u6240\u6709\uff0c\u5176\u77e5\u8bc6\u4ea7\u6743\u8f6c\u8ba9\u4e0d\u5b58\u5728\u7248\u7a0e\u6216\u5176\u4ed6\u8d1f\u62c5\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002 \u8be5\u201c\u8bb8\u53ef\u901a\u77e5\u201d\u8bc1\u5b9e\u4e86\u8be5\u516c\u53f8\u7684\u795e\u7ecf\u4fdd\u62a4\u80bd\u4e13\u5229\u7533\u8bf7\u5df2\u88ab\u5141\u8bb8\u53d1\u653e\uff0cArgenica\u9884\u8ba1\u8be5\u4e13\u5229\u5c06\u5728\u51e0\u4e2a\u6708\u5185\u5f97\u5230\u6b63\u5f0f\u6388\u4e88\u3002 ARG-007\u662f\u4e00\u79cd\u795e\u7ecf\u4fdd\u62a4\u6cbb\u7597\u836f\u7269\uff0c\u5728\u52a8\u7269\u6a21\u578b\u4e2d\u5df2\u88ab\u8bc1\u660e\u53ef\u4ee5\u51cf\u5c11\u4e2d\u98ce\u3001TBI\u548cHIE\u540e\u7684\u8111\u7ec6\u80de\u6b7b\u4ea1\u3002 \u76ee\u524d\u6b63\u5728\u8fdb\u884c\u5b89\u5168\u6027\u548c\u6bd2\u6027\u9a8c\u8bc1\uff0c\u5e76\u5c06\u4e8e\u660e\u5e74\u521d\u5f00\u59cb\u8fdb\u884c\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002 Argenica\u5e0c\u671b\u8fd9\u79cd\u836f\u7269\u80fd\u591f\u88ab\u4e00\u7ebf\u53cd\u5e94\u8005\u7528\u6765\u4fdd\u62a4\u8111\u7ec4\u7ec7\u5728\u4e2d\u98ce\u671f\u95f4\u514d\u53d7\u635f\u4f24\uff0c\u5e76\u6709\u8fdb\u4e00\u6b65\u7684\u6f5c\u529b\u5728\u4e2d\u98ce\u53d1\u751f\u540e\u4fc3\u8fdb\u6062\u590d\u3002 \u5176\u4ed6\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5 \u8be5\u4e13\u5229\u7533\u8bf7\u8fd8\u6db5\u76d6\u4e86\u8be5\u836f\u7269\u5728\u5176\u4ed6\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u4e2d\u7684\u5e94\u7528\uff0c\u5982\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u3001\u4ea8\u5ef7\u987f\u6c0f\u75c5\u3001\u591a\u53d1\u6027\u786c\u5316\u75c7\u3001\u5e15\u91d1\u68ee\u75c5\u3001\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u3001\u795e\u7ecf\u6027\u75bc\u75db\u3001\u810a\u9ad3\u635f\u4f24\u548c\u766b\u75eb\u3002 \u8be5\u7814\u7a76\u4e3aARG-007\u5728\u7f8e\u56fd\u7684\u5e7f\u6cdb\u5e94\u7528\u63d0\u4f9b\u4e86\u4fe1\u5fc3\uff0c\u5982\u679cARG-007\u80fd\u591f\u83b7\u5f97\u5728\u8fd9\u4e9b\u6761\u4ef6\u4e0b\u8fdb\u884c\u5f00\u53d1\u6240\u9700\u7684\u529f\u6548\u6570\u636e\uff0cARG-007\u5c31\u53ef\u4ee5\u5728\u7f8e\u56fd\u8fdb\u884c\u5546\u4e1a\u5316\u3002 \u91cd\u8981\u7684\u4e00\u6b65 Argenica\u9996\u5e2d\u6267\u884c\u5b98Liz Dallimore\u535a\u58eb\u8bf4\uff0c\u8bb8\u53ef\u901a\u77e5\u662f\u836f\u7269\u5f00\u53d1\u8fc7\u7a0b\u4e2d\u7684\u91cd\u8981\u4e00\u6b65\u3002 \u5979\u8bf4:\u201c\u4e2d\u98ce\u3001\u8111\u5916\u4f24\u548cHIE\u662f\u7f8e\u56fd\u5de8\u5927\u7684\u672a\u6ee1\u8db3\u533b\u7597\u9700\u6c42\u7684\u75be\u75c5\uff0c\u4ee3\u8868\u7740\u6211\u4eec\u5c06\u5bfb\u627e\u7684\u76ee\u6807\u5e02\u573a\u3002\u201d \u201c\u6388\u4e88\u8be5\u4e13\u5229\u5c06\u589e\u5f3a\u6211\u4eec\u672a\u6765\u4e0e\u7f8e\u56fd\u5236\u836f\u516c\u53f8\u8fdb\u884c\u5546\u4e1a\u8c08\u5224\u7684\u80fd\u529b\u3002\u201d \u884c\u7a0b\u7684\u7edf\u8ba1\u6570\u636e \u5728\u7f8e\u56fd\uff0c\u6bcf\u5e74\u7ea6\u670979.5\u4e07\u4eba\u4e2d\u98ce;150\u4e07\u4eba\u906d\u53d7\u521b\u4f24\u6027\u8111\u635f\u4f24;\u5927\u7ea6\u6bcf1000\u4e2a\u6d3b\u4ea7\u513f\u4e2d\u5c31\u67094\u4e2a\uff0c\u591a\u8fbe60%\u7684\u65e9\u4ea7\u513f\u60a3\u6709HIE\u3002 Argenica\u5df2\u7ecf\u4e3aARG-007\u5728\u6b27\u76df(11\u4e2a\u4e3b\u8981\u56fd\u5bb6\u9a8c\u8bc1)\u3001\u65e5\u672c\u548c\u4e2d\u56fd\u7684\u5927\u578b\u6f5c\u5728\u5e02\u573a\u6388\u4e88\u4e86\u4e13\u5229\u3002 \u8fd9\u4e9b\u4e13\u5229\u5b8c\u5168\u5f52\u963f\u6839\u5ef7\u6240\u6709\uff0c\u5176\u77e5\u8bc6\u4ea7\u6743\u8f6c\u8ba9\u4e0d\u5b58\u5728\u7248\u7a0e\u6216\u5176\u4ed6\u8d1f\u62c5\u3002<\/p>\n","protected":false},"author":4,"featured_media":14190,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[888],"yoast_head":"\n
Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269<\/title>\n<meta name=\"description\" content=\"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269\" \/>\n<meta property=\"og:description\" content=\"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-09T01:43:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:52:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-patent-United-States-US-stroke-TBI-HIE-ARG-007.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/\",\"name\":\"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-12-09T01:43:48+00:00\",\"dateModified\":\"2023-08-29T17:52:17+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269","description":"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269","og_description":"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/","og_site_name":"smallcapsCN","article_published_time":"2021-12-09T01:43:48+00:00","article_modified_time":"2023-08-29T17:52:17+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-patent-United-States-US-stroke-TBI-HIE-ARG-007.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/","url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/","name":"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-12-09T01:43:48+00:00","dateModified":"2023-08-29T17:52:17+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u65e5\u524d\uff0c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u6279\u51c6\u4e86Argenica Therapeutics (ASX: AGN)\u7684\u4e3b\u8981\u836f\u7269ARG-007\u7684\u521d\u6b65\u4e13\u5229\uff0cARG-007\u53ef\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24(TBI)\u548c\u7f3a\u6c27\u7f3a\u8840\u6027\u8111\u75c5(HIE)\u60a3\u8005\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-preliminary-us-patent-approval-lead-drug-treat-stroke-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Argenica Therapeutics\u521d\u6b65\u83b7\u5f97\u7f8e\u56fd\u4e13\u5229\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u4e2d\u98ce\u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4349"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4349"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4349\/revisions"}],"predecessor-version":[{"id":14189,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4349\/revisions\/14189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/14190"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}